Patient Engagement Specialist
I am a Patient Engagement Specialist, who is passionate about the psycho social impact of chronic diseases among patients and their families, especially on their work and income. Having retrained in European Market Access, I have found it meaningful to start integrating some of the economic and patient access aspects of the psycho social impact into my Patient Engagement work.
Additionally, timely and relevant provision of information topics beyond the signs and symptoms of disease pathophysiology is also a focus of my work.
My work experiences that have had a profound influence in leading me to becoming a Patient Engagement Specialist include:
B Pharm (Hons), MPH, MBM
Gurmit Sandhu Consulting GmbH (# 7-028010-03)
Am Krayenrain 3, Basel 4056 Switzerland
Mobile +41 79 264 9929
Office: +41 61 271 0029
I am a certified Personality Coach, Art-Therapist and Artist. I am highly interested in people, personalities and their different life processes. Over the years, I have gathered and studied a variety of approaches to personal development – originating from Psychology, Psycho-Therapy, Hypnosis, Brain-Science and Quantum Physics, alternative healing methods and ancient spiritual knowledge.
10 years of life and work in the Middle East have made me aware about the uniqueness of each human being and sharpened my intuition for treating each of them individually, keeping my mind open for miracles.
Meanwhile I have developed my own, special ‚toolbox‘ to guide, support and empower people individually during their life-struggles. The tools people ask for the most: typology analysis and art therapy.
My clients are patients, business people, couples, single mums, students, children, or artists – I help them to de-stress and unblock, to recognize their true Self, re-connect with their source, to unfold their true personality and to develop their own creative and successful strategy to live a happy and healthy life.
Martina Dresler, Personality Coach & Art Therapist (IHK)
Breisacherstrasse 131, 4057 Basel
Market Access & HTA Expert
Anke is the founder of the Health Outcomes Strategies, ltd (www.health-os.com). Her areas of expertise are value of healthcare products and policy decisions on healthcare products for the in- and off-patent sector, reimbursement strategies, outcomes research and health economics, health technology assessment processes, payer interactions, product / device / service synergies. In addition, she is engaged in patient involvement initiatives.
Anke has served as visiting faculty at the University of Utah between 2006 and 2007 and remains adjunct assistent professor at the Pharmacotherapy Outcomes Research Center at the University of Utah College of Pharmacy, where she in addition to her academic contributions participated as investigator in a variety of outcomes studies. She has published broadly, among others on subjects of evidence based decision making and quality control in healthcare. As member of the Health Technology Assessment international Association (HTAi) and the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) she is engaged in the workgroups for Patient and Citizen Involvement in HTA, for Precision Medicines Methods and for Health Technology Assessment for pharmaceuticals, medical devices and diagnostics. Anke has also been appointed as evaluator at the EU-commission on multiple occasions and serves on the permanent accreditation boards for university programs in Germany.
Anke obtained her PhD in natural sciences (Dr.rer.nat) from the University of Marburg (Germany) and her MBA from the University of Birmingham (United Kingdom). She looks back on over 25 years of experience in the pharmaceutical and chemical industry in research and marketing with global responsibilities. Among others, she was responsible for the global Disease Management strategy and activities of Novartis Pharma, AG. Between 2000 and 2004, Anke managed the biotech business unit of a midsized Swiss chemical company and held a seat in the executive committee. Previously, she was responsible for technical development in the field of products of biologics in mammalian cell culture in the pharmaceutical industry. Contact: via this website